Oxymorphone Extended Release Does Not Affect CYP2C9 or CYP3A4 Metabolic Pathways-Reference-Cited by-同舟云学术

Oxymorphone Extended Release Does Not Affect CYP2C9 or CYP3A4 Metabolic Pathways

Published:2005-03 Issue:3 Volume:45 Page:337-345
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Adams Michael,Pieniaszek Henry J.,Gammaitoni Arnold R.,Ahdieh Harry

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference15 articles.

1. Oxymorphone revisited;Sinatra;Semin Anesth,1988

2. The analgesic equivalence to morphine and relative side action liability of oxymorphone (4-hydroxydihydromorphinone);Eddy;J Pharmacol Exp Ther.,1959

3. Pharmaceuticals P TIMERx control release delivery systems http://www.penwest.com/timerx.html

4. Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: results of a randomized crossover study;Adams;Pharmacotherapy,2004

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Larvicidal and Growth Inhibitory Activities of Ageratum houstonianum (Mill, 1768) Against the Dengue Vector Aedes aegypti (Linnaeus, 1762);Gazi Entomolojik Arastirmalar Dernegi;2022-12-01

2. Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches;Journal of Medicinal Chemistry;2021-05-18

3. Cytochrome P450 3A Time-Dependent Inhibition Assays Are Too Sensitive for Identification of Drugs Causing Clinically Significant Drug-Drug Interactions: A Comparison of Human Liver Microsomes and Hepatocytes and Definition of Boundaries for Inactivation Rate Constants;Drug Metabolism and Disposition;2021-04-02

4. Opioids in Pain;Pain Care Essentials and Innovations;2021

5. Physiologically Based Pharmacokinetic Modeling of Doravirine and Its Major Metabolite to Support Dose Adjustment With Rifabutin;The Journal of Clinical Pharmacology;2020-09-28